Invitrogen™ Human EVER2 Synthetic Peptide

Ref.: BL-RE-177151Manufacturer ref.: PEP-0646 50 μg
€149.00 excl. VAT

EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.

Gene ID (Enter)
147138
Species
Human
Purification method
Purified
Accession number
Q8IU68
Common name
Human EVER2
Brand
Invitrogen

EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.

EVER2 Synthetic Peptide, PEP-0646, from Invitrogen.

Epidermodysplasia verruciformis (EV) is an autosomal recessive genodermatosis associated with a high risk of skin cancers resulting from a high susceptibility to infection by specific human papillomaviruses. Mutations in two homologous genes EVER1 and EVER2 cause the majority of EV cases. These two proteins form a complex and interact with the zinc transporter ZnT-1 in the endoplasmic reticulum. Cells lacking EVER2 accumulated higher levels of zinc in the nucleolus and nucleus compare to those cells with and intact EVER2 gene, indicating that one role of EVER2 is to regulate the intracellular distribution of zinc.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15318840
Specifications
Gene ID (Enter)147138
SpeciesHuman
Purification methodPurified
Accession numberQ8IU68
Common nameHuman EVER2
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)TMC8
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-0646
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.